Compare CERT & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CERT | POET |
|---|---|---|
| Founded | 2008 | 1972 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Semiconductors |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2020 | 2008 |
| Metric | CERT | POET |
|---|---|---|
| Price | $10.03 | $5.28 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $9.17 | N/A |
| AVG Volume (30 Days) | 2.6M | ★ 7.3M |
| Earning Date | 11-05-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $418,838,000.00 | N/A |
| Revenue This Year | N/A | $211.20 |
| Revenue Next Year | $2.54 | $2,864.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $4.45 | $3.87 |
| 52 Week High | $12.94 | $20.65 |
| Indicator | CERT | POET |
|---|---|---|
| Relative Strength Index (RSI) | 61.78 | 28.31 |
| Support Level | $8.82 | $5.10 |
| Resistance Level | $10.20 | $8.47 |
| Average True Range (ATR) | 0.54 | 0.39 |
| MACD | 0.04 | -0.14 |
| Stochastic Oscillator | 83.53 | 1.43 |
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.